Integra LifeSciences Holdings Corporation (IART)
Oxford Ledge is still expanding full research coverage of IART. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
The company manufactures medical devices subject to extensive domestic and foreign regulatory oversight governing product approval, safety, marketing and compliance with healthcare and anti-corruption laws.
SEC filings
- 8-K Departure/election of directors or officers; Shareholder vote results; Financial statements and exhibits 2026-05-08
- 10-Q Quarterly financial report (unaudited) 2026-05-05
- 8-K Departure/election of directors or officers; Financial statements and exhibits 2026-05-05
- 8-K Results of operations / financial condition; Financial statements and exhibits 2026-05-05
- 8-K Entry into material agreement 2026-04-15
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for IART. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open IART in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.